Integrated Clinical Trial Services Releases Podcast On Pre-Launch Education For Clinical Trials
Submitted by: MMI Public Relations
2008-12-23 03:01:49
Dr. David M. Shearer Discusses How Patient Education Benefits Trial Results
Raleigh, NC (OPENPRESS) December 23, 2008 -- Tom Sturgis, president of Integrated Clinical Trial Services (ICTS), a full-service patient enrollment firm that utilizes more than 300 contract employees internationally to provide clinical trial patient recruitment, enrollment, retention and adherence, has announced the release of a podcast discussing the impact of pre-launch education for clinical trials. In the podcast, Dr. David M. Shearer, chief medical officer and vice president of clinical operations at ICTS, discusses how pre-launch patient education can stimulate a higher return on investment for patient compliance during a clinical trial. The podcast is now available for download at www.mmimarketing.com/files/davidshearerprelauncheducation.mp3.
Related Links:
www.integratedtrials.com
www.mmimarketing.com/files/davidshearerprelauncheducation.mp3
www.mmimarketing.com
News Facts:
• Tom Sturgis, president of Integrated Clinical Trial Services (ICTS), a full-service patient enrollment firm that utilizes more than 300 contract employees internationally to provide clinical trial patient recruitment, enrollment, retention and adherence, has announced the release of a podcast discussing the impact of pre-launch education for clinical trials.
• In the podcast, Dr. David M. Shearer, chief medical officer and vice president of clinical operations at ICTS, discusses how pre-launch patient education can stimulate a higher return on investment for patient compliance for clinical trials.
• The podcast is now available for download at www.mmimarketing.com/files/davidshearerprelauncheducation.mp3.
Quotes:
"Too many times in the informed consent process of a clinical trial, the patient is not adequately informed of what they are signing up for," said Shearer. "Information about what a clinical trial involves needs to be explained to the patient. It is important to engage the subject and make them aware of what they can expect in their given condition during a trial."
About Integrated Clinical Trial Services:
Integrated Clinical Trial Services is a creative, innovative and flexible partner for clinical trial patient recruitment, enrollment, retention and adherence. The full-service firm utilizes more than 300 contract employees internationally to provide patient enrollment feasibility, recruitment strategy, consulting, market research and protocol review, project management, concept design and production, media placement, community resource support, compliance and retention, and more. The Integrated Clinical Trial Services management team has completed more than 300 successful patient recruitment programs and combines for more than 60 years of active involvement in patient accrual. A successful trial depends on the quality of the underlying recruitment plan and Integrated Clinical Trial Services is dedicated to constructing the right solution based upon each client's protocol and needs. For more information please call (919) 388-3964 or visit the Web site at www.integratedtrials.com.
